在瘤学中药物再利用:释放新的治疗潜力的战略途径
Rahaman Shaik1,2, Sai Geethika Laddika3, Madiha Unnisa3
1Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. shaikrahaman_sch@jamiahamdard.ac.in.
Therapeutic innovation & regulatory science
|November 19, 2025
概括
药物重新定位通过使用现有药物,为新的癌症免疫疗法提供了更快的途径. 这些重新定位的药物可以通过向瘤微环境和免疫细胞来增强免疫检查点抑制剂 (ICI) 等治疗方法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症病例和死亡需要新的治疗策略.
- 药物重新定位通过利用已知安全性概况的现有药物加速发现新的癌症疗法.
- 重新设计的药物可能会增强当前的癌症免疫疗法,包括免疫检查点抑制剂 (ICI).
研究的目的:
- 探索药物重定向在改善癌症免疫疗法的潜力.
- 确定特定的重用药物及其作用机制,以增强抗瘤免疫力.
- 讨论在临床癌症治疗中实施药物重定向的挑战和未来方向.
主要方法:
- 对癌症免疫治疗中药物重用现有文献的综述.
- 分析重定向药物调节瘤微环境和免疫反应的机制.
- 特定药物类别和示例的识别,包括RANKL抑制剂,TGF-β抑制剂,甲型胺,GM-CSF,氨酸α1和阿司匹林.
主要成果:
- 重用药物可以通过影响瘤微环境,促进T细胞激活和克服抵抗来增强ICI.
- 具体的例子包括RANKL抑制剂 (增强免疫细胞),TGF-β抑制剂 (改善T细胞透),甲胺 (激活细胞毒性T淋巴细胞),GM-CSF和氨酸α1 (增强T细胞活性和树突细胞成熟),以及阿司匹林 (阻断瘤衍生的免疫抑制).
结论:
- 药物重新定位对推进癌症免疫疗法和改善患者治疗结果具有重大前景.
- 挑战包括优化剂量,管理非目标效应和导航监管途径.
- 个性化医学和人工智能的未来进展,以及跨学科的合作,对于实现瘤学中重新定位药物的全部潜力至关重要.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.1K
相关概念视频
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:28Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K